Bryan Johnson, the American entrepreneur and venture capitalist, has become a household name not just for his tech exits but for his relentless pursuit of biological immortality. Known for Project Blueprint, his extreme anti-aging protocol, Johnson spends millions annually in an attempt to reverse his biological clock. This article examines his wealth, his controversial regimen, his personal life, and the scientific questions surrounding his mission.
Born on August 22, 1977, in Provo, Utah, Johnson made his fortune by founding Braintree, the online payment platform that acquired Venmo and was later sold to PayPal for $800 million in 2013. He is now 48 years old and worth an estimated $400 million, a figure that fluctuates between $300 million and $500 million depending on market conditions and his personal spending on health.
Johnson’s public persona shifted dramatically in 2021 when he launched Project Blueprint, a highly regimented lifestyle protocol involving a strict diet, exercise, sleep schedule, and over 100 daily supplements. His stated goal is to achieve a biological age of 18 years old.
What is the Blueprint? Bryan Johnson’s Anti-Aging Project
Project Blueprint is a comprehensive system designed to optimize every measurable aspect of human health. Launched on October 13, 2021, the protocol involves a team of over 30 doctors who monitor more than 100 biological biomarkers. Johnson claims that the regimen has reversed his biological age by 5.1 years, making him appear nearly 10 years younger.
Comprehensive anti-aging protocol involving strict diet, exercise, sleep, and dozens of daily supplements.
Estimated at $400 million from the sale of Braintree/Venmo to PayPal in 2013.
Born in 1977, age 47 in 2025, 48 in 2026.
In a long-term relationship with Kate Tolo; has three children.
- Bryan Johnson spends over $2 million per year on his anti-aging regimen.
- He has a team of 30+ doctors monitoring his health.
- Johnson claims to have reversed his biological age by 5+ years.
- He is the founder of Braintree, Kernel, and OS Fund.
- His “Don’t Die” movement aims to eliminate death as a concept.
| Attribute | Detail |
|---|---|
| Full Name | Bryan Johnson |
| Born | 1977 (age 47 in 2025, 48 in 2026) |
| Net Worth | ~$400 million (range $300M–$500M) |
| Partner | Kate Tolo (co-founder of Blueprint) |
| Children | Three children (including a teenage son) |
| Education | University of Chicago Booth School of Business (MBA) |
| Notable Companies | Braintree, Venmo, Kernel, OS Fund, Blueprint |
| Project Blueprint Start | October 13, 2021 |
| Annual Health Cost | ~$2 million |
| Biological Age Claim | Reversed by 5.1 years |
| Target Biological Age | 18 years old |
| Philosophy | “Don’t Die” (global movement) |
How Old is Bryan Johnson?
Bryan Johnson was born on August 22, 1977, which makes him 48 years old as of July 2026. Despite his chronological age, he claims his biological age has been reduced significantly through his Blueprint protocol. He aims to reach a biological age of 18 years old.
What is Bryan Johnson’s Net Worth?
Johnson’s estimated net worth in 2025 is approximately $400 million, though some sources place the figure between $300 million and $500 million. The variation stems from market fluctuations and the significant spending on his anti-aging protocols.
His wealth originated primarily from the 2013 acquisition of Braintree by PayPal, where he personally netted around $300 million after taxes. He subsequently deployed $100 million to launch the OS Fund in 2014 and another $100 million (plus further outside capital) to launch Kernel in 2016. His Blueprint venture also generates revenue through the sale of supplements and foods.
How did Bryan Johnson make his money?
Johnson founded Braintree, an online payment platform, in 2007. In 2012, Braintree acquired Venmo, a mobile payment service. In 2013, PayPal acquired the combined company for $800 million. Johnson’s personal take from that sale was approximately $300 million after taxes. He has since invested heavily in his own ventures, including Kernel (brain-machine interfaces), OS Fund (venture capital), and Blueprint (anti-aging).
Bryan Johnson Before and After: Anti-Aging Results
Johnson regularly publishes data from his health monitoring, including blood work, scans, and photographs. He claims his regimen has reversed his biological age by 5.1 years, making him appear nearly 10 years younger. However, these claims are met with skepticism from many in the medical and scientific community.
The degree of biological age reversal is disputed. Some experts question the methodology used to calculate Johnson’s biological age. The long-term health effects of his aggressive regimen remain unknown, and his claims of “reversing age” are not widely accepted in mainstream geroscience.
Bryan Johnson’s Family: Wife, Son, and Children
Who is Bryan Johnson’s wife?
Bryan Johnson is not married. He is in a long-term relationship with Kate Tolo, who is a co-founder of his Blueprint venture. The relationship became public in December 2025.
Earlier reports had mentioned a wife named “Taryn,” but that information does not appear in current, verified sources. The only supported information is his current partnership with Kate Tolo.
Does Bryan Johnson have a son?
Yes, Johnson has a teenage son. In 2023, his son famously donated plasma to Johnson for a blood transfusion as part of an experimental anti-aging procedure. Johnson underwent six such plasma transfusion sessions in 2023, including one with his son, but later stopped the practice after determining it provided no measurable benefit.
Does Bryan Johnson have children?
Yes, Johnson has three children. Beyond the teenage son, the names and details of his other children have not been publicly detailed in verified sources.
Timeline of Bryan Johnson’s Journey
- 1977: Born in Provo, Utah.
- 2007: Founded Braintree, an online payment platform.
- 2012: Braintree acquired Venmo.
- 2013: Sold Braintree/Venmo to PayPal for $800 million. Johnson nets approximately $300 million after taxes.
- 2014: Launched OS Fund, a venture capital firm investing in deep tech. He personally invested $100 million.
- 2016: Founded Kernel, a company developing non-invasive brain-recording devices. He invested $100 million.
- 2021 (October 13): Launched Project Blueprint, his anti-aging protocol.
- 2023: Underwent six plasma transfusion sessions, including one with his teenage son, before stopping the practice.
- 2023-2025: Ongoing anti-aging experiments, regular updates to his protocol, and public data sharing.
What We Know and What Remains Unclear
| Established Information | Information That Remains Unclear |
|---|---|
| Bryan Johnson sold Braintree/Venmo to PayPal for $800 million. | The degree of biological age reversal is disputed; some experts question the methodology. |
| He is the founder of Kernel (brain-machine interfaces) and OS Fund (venture capital). | Long-term health effects of his aggressive regimen are unknown. |
| He follows an extreme anti-aging regimen documented on social media. | Claims of “reversing age” are not widely accepted in mainstream geroscience. |
| He has a team of 30+ medical professionals monitoring his health. | The replicability and scalability of his protocol for the general public remain unproven. |
The Context: Don’t Die and the Biohacking Movement
Bryan Johnson represents a modern extreme in the biohacking movement, combining significant wealth with a fanatical focus on measurable health metrics. His Blueprint protocol has drawn both admiration and skepticism. The context of increasing longevity research and the rise of quantified self provides a backdrop. Critics argue his approach is not scalable or scientifically rigorous, while supporters see it as pioneering.
Johnson’s philosophy is encapsulated in the movement “Don’t Die,” which he promotes globally. This framework aims to eliminate death as a concept, or at least drastically extend the human lifespan. His business background as a serial entrepreneur adds to his persuasive narrative and his ability to fund his own research.
For readers interested in other public figures navigating complex health and biographical narratives, the biography of RFK Jr. – Biography, Political Party, Wife, Age, and HHS Role offers a different perspective on public life and health policy. Similarly, the story of Paul Sinha – Biography, Parkinson’s Diagnosis and Career provides insight into a very different kind of health journey in the public eye.
Sources and Key Quotes
We may be the first generation who won’t die.
— Bryan Johnson (Instagram bio)
Johnson sold his company, Braintree Venmo, to PayPal for $800m in 2013.
— YouTube description
Bryan Johnson is the founder and former CEO of Kernel, a company creating devices that monitor and record brain activity.
Summary: What is the Bigger Picture?
Bryan Johnson’s story is one of extreme wealth, scientific ambition, and personal conviction. He has turned his body into a laboratory in an effort to conquer aging. Whether his protocol works as advertised is a matter of ongoing debate, but his actions have undeniably brought attention to the field of longevity research. His “Don’t Die” movement continues to grow, as does his influence on the biohacking community. He aims to achieve a biological age of 18 by 2030 and plans to scale his movement through documentaries and a potential open-source protocol.
Frequently Asked Questions
What is Kernel?
Kernel is a company founded by Bryan Johnson that develops non-invasive brain-computer interfaces to monitor and record brain activity.
What is OS Fund?
OS Fund is a venture capital firm founded by Bryan Johnson that invests in science and technology companies aiming to rewrite the operating systems of the universe.
How much does Bryan Johnson sleep?
Bryan Johnson reportedly aims for 8–9 hours of sleep per night as part of his Blueprint regimen, using sleep tracking devices to optimize quality.
Does Bryan Johnson take supplements?
Yes, he takes over 100 supplements daily, including NMN, metformin, rapamycin, and various vitamins, all timed according to his protocol.
Is Bryan Johnson’s anti-aging regimen safe?
The safety is debated. While he is under medical supervision, many of the drugs and dosages are experimental and not FDA-approved for anti-aging.
Priya Mehta is Economics & Policy Editor at TradeWireUK.uk, covering the UK economy, inflation, interest rates, fiscal policy and trade policy.